Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apyx Medical Corporation stock logo
APYX
Apyx Medical
$2.06
+4.8%
$1.76
$0.76
$2.73
$78.00M1.3184,970 shs28,230 shs
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
$3.13
-5.7%
$4.81
$1.05
$12.50
$20.61M-0.94345,511 shs20,021 shs
Fonar Corporation stock logo
FONR
Fonar
$16.18
-0.8%
$14.19
$12.00
$18.68
$100.37M118,035 shs13,605 shs
Nutriband Inc. stock logo
NTRB
Nutriband
$8.06
+0.3%
$7.19
$3.72
$11.78
$89.81M1.1588,831 shs10,109 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apyx Medical Corporation stock logo
APYX
Apyx Medical
-6.19%-23.64%+12.57%+93.14%+42.75%
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
-1.78%-18.23%-38.52%-38.63%+331,999,900.00%
Fonar Corporation stock logo
FONR
Fonar
+2.90%+5.50%+12.10%+34.35%-1.98%
Nutriband Inc. stock logo
NTRB
Nutriband
+1.01%-5.08%+12.45%+63.75%+22.75%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Apyx Medical Corporation stock logo
APYX
Apyx Medical
1.8182 of 5 stars
0.04.00.04.21.61.70.6
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/AN/AN/AN/AN/AN/AN/AN/A
Fonar Corporation stock logo
FONR
Fonar
1.2521 of 5 stars
0.03.00.00.01.90.81.9
Nutriband Inc. stock logo
NTRB
Nutriband
3.0767 of 5 stars
3.54.00.00.02.71.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Apyx Medical Corporation stock logo
APYX
Apyx Medical
2.67
Moderate BuyN/AN/A
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
0.00
N/AN/AN/A
Fonar Corporation stock logo
FONR
Fonar
0.00
N/AN/AN/A
Nutriband Inc. stock logo
NTRB
Nutriband
3.00
Buy$13.0061.21% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Apyx Medical Corporation stock logo
APYX
Apyx Medical
$48.10M1.62N/AN/A$0.38 per share5.43
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
$37.04M0.56N/AN/AN/A
Fonar Corporation stock logo
FONR
Fonar
$103.02M0.97$3.14 per share5.15$24.78 per share0.65
Nutriband Inc. stock logo
NTRB
Nutriband
$2.14M42.02N/AN/A$0.58 per share13.90
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Apyx Medical Corporation stock logo
APYX
Apyx Medical
-$23.46M-$0.55N/AN/AN/A-42.37%-156.85%-31.92%8/6/2025 (Estimated)
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/AN/A0.00N/AN/AN/AN/AN/A
Fonar Corporation stock logo
FONR
Fonar
$10.57M$1.2512.94N/A8.19%5.31%3.97%9/25/2025 (Estimated)
Nutriband Inc. stock logo
NTRB
Nutriband
-$10.48M-$0.90N/AN/AN/A-415.93%-68.25%-60.40%9/2/2025 (Estimated)

Latest BDMD, FONR, APYX, and NTRB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/30/2025Q1 2026
Nutriband Inc. stock logo
NTRB
Nutriband
-$0.13-$0.12+$0.01-$0.12$0.71 million$0.67 million
5/15/2025Q3 2025
Fonar Corporation stock logo
FONR
Fonar
N/A$0.37N/A$0.37N/AN/A
5/8/2025Q1 2025
Apyx Medical Corporation stock logo
APYX
Apyx Medical
-$0.13-$0.10+$0.03-$0.10$9.39 million$9.43 million
4/28/2025Q4 2025
Nutriband Inc. stock logo
NTRB
Nutriband
-$0.12-$0.18-$0.06-$0.51$0.71 million$0.64 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Apyx Medical Corporation stock logo
APYX
Apyx Medical
N/AN/AN/AN/AN/A
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/AN/AN/AN/AN/A
Fonar Corporation stock logo
FONR
Fonar
N/AN/AN/AN/AN/A
Nutriband Inc. stock logo
NTRB
Nutriband
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Apyx Medical Corporation stock logo
APYX
Apyx Medical
3.21
5.45
4.64
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/AN/AN/A
Fonar Corporation stock logo
FONR
Fonar
N/A
10.05
9.86
Nutriband Inc. stock logo
NTRB
Nutriband
0.01
3.71
3.48

Institutional Ownership

CompanyInstitutional Ownership
Apyx Medical Corporation stock logo
APYX
Apyx Medical
55.33%
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
19.78%
Fonar Corporation stock logo
FONR
Fonar
50.64%
Nutriband Inc. stock logo
NTRB
Nutriband
19.70%

Insider Ownership

CompanyInsider Ownership
Apyx Medical Corporation stock logo
APYX
Apyx Medical
15.20%
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
78.90%
Fonar Corporation stock logo
FONR
Fonar
1.55%
Nutriband Inc. stock logo
NTRB
Nutriband
54.09%
CompanyEmployeesShares OutstandingFree FloatOptionable
Apyx Medical Corporation stock logo
APYX
Apyx Medical
27037.79 million32.05 millionOptionable
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/A6.58 million1.39 millionN/A
Fonar Corporation stock logo
FONR
Fonar
4806.20 million6.11 millionNot Optionable
Nutriband Inc. stock logo
NTRB
Nutriband
1011.15 million5.12 millionNot Optionable

Recent News About These Companies

Nutriband (NTRB) Gets a Buy from Noble Financial
Nutriband (NASDAQ: NTRB) Charts Path to Commercialization

New MarketBeat Followers Over Time

Media Sentiment Over Time

Apyx Medical stock logo

Apyx Medical NASDAQ:APYX

$2.06 +0.09 (+4.77%)
As of 12:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Baird Medical Investment stock logo

Baird Medical Investment NASDAQ:BDMD

$3.13 -0.19 (-5.72%)
As of 12:10 PM Eastern

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.

Fonar stock logo

Fonar NASDAQ:FONR

$16.18 -0.13 (-0.80%)
As of 12:35 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

Nutriband stock logo

Nutriband NASDAQ:NTRB

$8.06 +0.02 (+0.30%)
As of 12:39 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.